Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 1Phase 1/2 1Phase 1 1

Status

Completed 60Recruiting 24Unknown 19Terminated 6Not yet recruiting 5Active not recruiting 5Withdrawn 4Enrolling by invitation 4

Sponsor Class

INDUSTRY 3OTHER 2NIH 1

Study Type

Interventional 6Observational 3

Sponsor

Cancer Type

Plasma cell 1CNS 1

Conditions

Breast Neoplasms 989Neoplasms 848Carcinoma, Non-Small-Cell Lung 842Prostatic Neoplasms 527Neoplasm Metastasis 500Leukemia, Myeloid, Acute 488Melanoma 453Colorectal Neoplasms 446Multiple Myeloma 440Lung Neoplasms 419Pancreatic Neoplasms 352Recurrence 350Lymphoma 349Ovarian Neoplasms 341Lymphoma, Non-Hodgkin 327Leukemia 323Leukemia, Lymphocytic, Chronic, B-Cell 301Precursor Cell Lymphoblastic Leukemia-Lymphoma 271Carcinoma, Renal Cell 256Head and Neck Neoplasms 246Brain Neoplasms 243Carcinoma, Hepatocellular 234Squamous Cell Carcinoma of Head and Neck 231Glioblastoma 231Myelodysplastic Syndromes 229Lymphoma, Large B-Cell, Diffuse 228Lymphoma, Follicular 219Colonic Neoplasms 191Stomach Neoplasms 182Rectal Neoplasms 175

Interventions

salicylsalicylic acid 1XENP 1595 1Interleukin 1 Receptor Antagonist Protein 1Etanercept 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Terminated × Interventional × Inflammation × Clear all
NCT05522387 2026-02-27

An Open-Label Extension of XPro1595 in Patients With Alzheimer's Disease

Inmune Bio, Inc.

Phase 2 Terminated
11 enrolled
CNS

Alzheimer Disease, Mental Disorders, Brain Diseases, Central Nervous System Diseases, Dementia, Inflammation, Nervous System Diseases, Neurodegenerative Diseases, Neurocognitive Disorders, Tauopathies

NCT04271930 2024-10-09

Effect of Sleep Quality on Hematopoietic Cell Transplant Patient Outcomes

Medical College of Wisconsin

Phase NA Terminated
24 enrolled
Plasma cell

Sleep Hygiene, Depression, Fatigue, Inflammation, Sleep Initiation and Maintenance Disorders, Multiple Myeloma

NCT03283826 2024-02-23

EMBOLD

Atara Biotherapeutics

Phase 1/2 Terminated
134 enrolled

Autoimmune Diseases, Demyelinating Diseases, Inflammation, Multiple Sclerosis, Epstein-Barr Virus Infections, Multiple Sclerosis, Chronic Progressive

NCT00031551 2017-12-06

Evaluation of Efficacy and Mechanisms of an Antiinflammatory Intervention for Chemotherapy Related Mucosal Injury

National Institutes of Health Clinical Center (CC)

Phase 2 Terminated
27 enrolled 10 charts

Inflammation, Neoplasms, Stomatitis

NCT01489319 2017-02-10

ELI-ROAS

Indiana University

Phase 1 Terminated
47 enrolled

Inflammation, Insulin Resistance, Polycystic Ovary Syndrome, Hyperandrogenism

NCT00537667 2009-11-26

The SPECTRA Study

Swedish Orphan Biovitrum

Phase 2 Terminated
22 enrolled

Arthritis, Rheumatoid, Inflammation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡